A detailed history of Palisade Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Palisade Capital Management LLC holds 1,986 shares of MRK stock, worth $194,727. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,986
Previous 2,936 32.36%
Holding current value
$194,727
Previous $363,000 38.02%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $105,592 - $122,521
-950 Reduced 32.36%
1,986 $225,000
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $4,209 - $4,520
-34 Reduced 1.14%
2,936 $363,000
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $44,390 - $51,724
-392 Reduced 11.66%
2,970 $391,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $5,539 - $6,037
51 Added 1.54%
3,362 $387,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $289,513 - $371,196
3,311 New
3,311 $367,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.